Advertisement

Topics

FDA grants orphan status to Reata's melanoma drug

06:29 EDT 14 Sep 2017 | SmartBrief

Reata Pharmaceuticals' omaveloxolone was granted orphan drug designation by the FDA as a treatment for patients with stage II -More

Original Article: FDA grants orphan status to Reata's melanoma drug

NEXT ARTICLE

More From BioPortfolio on "FDA grants orphan status to Reata's melanoma drug"

Quick Search
Advertisement
 

Relevant Topic

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...